<DOC>
	<DOCNO>NCT00917748</DOCNO>
	<brief_summary>The primary objective : - To determine efficacy modafinil reduction fatigue patient metastatic breast prostate cancer undergo docetaxel-based chemotherapy The secondary objective : - To determine effect modafinil quality life ( QoL ) docetaxel-based chemotherapy - To determine effect modafinil patient physical activity level , functional status , number chemotherapy cycle tolerate , sleep disturbance depression , docetaxel-based chemotherapy - To investigate impact tumour type , patient physical activity level , functional status , sleep disturbance depression efficacy modafinil improve fatigue quality life docetaxel-based chemotherapy . - To determine safety tolerability modafinil docetaxel-based chemotherapy</brief_summary>
	<brief_title>Study With Modafinil Patients Treated With Docetaxel-Based Chemotherapy Metastatic Breast Prostate Cancer ( MOTIF )</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Inclusion criterion : Treatment q3w ( every three week ) docetaxelbased chemotherapy metastatic breast prostate cancer minimum dose 50 mg/m2 Completed least two cycle chemotherapy intention treat patient least two cycle docetaxelbased chemotherapy Fatigue &gt; = 4 MD Anderson Symptom Inventory fatigue assessment scale previous docetaxel chemotherapy cycle SPHERE somatic ( SOMA ) subscale score &gt; = 3 Worsening fatigue commencement docetaxel chemotherapy Haemoglobin ( Hb ) &gt; = 10 g/dL within two week randomisation Exclusion criterion : Unable complete MD Anderson Symptom Inventory fatigue assessment scale Functional Assessment Chronic Illness TherapyFatigue Quality Life survey Require docetaxel chemotherapy dose reduction le 50 mg/m2 History chronic fatigue condition Uncontrolled hypertension ( blood pressure &gt; = 150/90 mm Hg Known hypersensitivity / intolerance modafinil excipients Pregnant woman Psychological , familial , sociological , geographical condition permit treatment medical followup / prohibit compliance study protocol Any serious concomitant illness , opinion Investigator , would preclude patient participate study NonEnglish speak The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>